Silgan Holdings Inc. has acquired Unicep Packaging, a specialty contract manufacturer and developer that develops, formulates, manufactures and sells precision dosing dispensing packaging solutions, such as diagnostic test components, oral care applications and skin care products, primarily for the health care, diagnostics, animal health, oral care and personal care markets. The reported price tag was $237 million.
Unicep is forecast to generate about $45 million in sales and approximately $18.3 million in adjusted EBITDA for 2021. It operates two manufacturing facilities located in Spokane, Washington and Sandpoint, Idaho.
“Unicep is a clear leader in the rapid development and manufacturing of differentiated precision dosing dispensing packaging solutions for applications in health care, diagnostics and personal care," said Adam Greenlee, president and CEO. "This acquisition further expands and extends our precision dosing capabilities and comprehensive product offering into new and existing markets. The Unicep team has combined a high-touch commercial philosophy with a proprietary operating platform to excel at meeting the unique requirements of their customers. The business broadens our exposure to health care and point-of-care diagnostics markets, has existing capacity for continued growth, complements our global dispensing and specialty closures franchise and is scalable across our global footprint. We believe the acquisition of Unicep represents another example of our disciplined capital allocation model that has allowed Silgan to consistently create long-term shareholder value, and we look forward to welcoming our newest employees to the Silgan team.”